The FDA could approve a new drug to treat Alzheimer's disease

On January 6, the FDA is expected to announce the approval of a new Alzheimer's drug called lecanemab.

Related Keywords

Graciela Perez ,Ginny Funk ,Mary Helen Ortiz ,Alzheimer Association ,Friday January ,Helen Ortiz ,Alzheimer X27 S ,Fda ,Disease ,Lecanemab ,New Drug ,